
KBI Biopharma, Inc. provides global biopharmaceutical development, manufacturing, and consulting services.
kbibiopharma.comCrawled Oct 16, 2026
KBI's process and analytical development capabilities support active product generation and transfer to cGMP manufacturing.
KBI's capabilities include CLD, process, analytical and formulation development, clinical and commercial manufacturing, characterization and consulting, and cell therapy.
KBI can apply established mammalian and microbial recombinant protein expression systems to provide rapid cell line generation services.
KBI Biopharma offers cGMP biologics manufacturing services, including clinical and commercial production, ensuring high-quality therapeutics and vaccines to meet global regulatory standards.
The page describes what it is like to be part of KBI Biopharma.
Processes for purification of BsAbs using Amsphere A3 affinity chromatography and two polishing steps to eliminate undesirable homodimers and impurities.
KBI Biopharma shares news about collaborations, awards, and antibody manufacturing, along with industry advancements and events.
The page lists KBI Biopharma events, conferences, presentations, publications, and news.
Archived content
The KBI and Selexis co-location will expand biopharmaceutical development and manufacturing capabilities to serve the global demand for novel therapies.
A collection of the latest news and updates from KBI Biopharma.
Job listings for KBI Biopharma's facilities: Durham, Research Triangle Park, and Patriot Park (NC), Boulder and Louisville (CO), and Geneva, Switzerland.
The page features a conversation with Elyse Blazevich, president and CEO of Colorado BioScience Association and president of Colorado BioScience Institute, about CBSA's role in collaboration, health innovation, and growth in Colorado's bioscience community.
KBI says its people support its commitment to improving patient outcomes; Lester Ojeda, Director of Supply Chain, is driven by that purpose.
KBI announces that Amy Sabeh was named an HBA Rising Star.
About page for Andrew Setikas, Senior Vice President of Business Development at KBI Biopharma.
Brian Ridout Interim Site Head & Sr. Director, Manufacturing – Hamlin Road, NC, United States
David Berger - Sr. Vice President and General Counsel
Debra Bruneau - Chief People Officer
The page describes KBI Biopharma's mission, values, and expertise in biologics development and manufacturing.
KBI is a biopharma CDMO that aims to accelerate development of biological products and expand global access to medicines for patients in need.
KBI Biopharma operates facilities across the globe.
The page invites inquiries about KBI Biopharma's services and offers assistance.
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, and more.
KBI Biopharma says it collects and protects personal information and uses cookies and analytics to enhance user experience.